N/A
N=5,702
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
Other Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03609177 ↗Enrolled (actual)
5,702
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Number of Participants With Advance Care Planning Documentation — 0; 1163; 349; 901 Participants — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Clinician Communication Skills Training (Other); Advance Care Planning (ACP) Decisions Videos Decisions Aids (Other); Video Declarations (ViDec) (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Dana-Farber Cancer Institute
- Primary completion
- Nov 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Advance Care Planning Documentation |
0; 1163; 349; 901; 886; 511 | <0.05 sig |
| SECONDARY Number of Participants With CODE Status Limitations |
0; 303; 58; 205; 155; 142 | <0.05 sig |
| SECONDARY Rate of Palliative Care Consultation |
0; 531; 102; 375; 324; 253 | <0.05 sig |
| SECONDARY Rate of Hospice Use |
0; 491; 50; 348; 260; 202 | <0.05 sig |
| SECONDARY Confidence in Future Care |
4; 4; 13; 8; 27; 15 | — |
| SECONDARY Communication and Decisional Satisfaction |
44; 44 | — |
| SECONDARY Decisional Regret |
2; 2 | — |
Summary
In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery.
- It is expected that about 30,000 people will take part in this research study, 29,550 of these patients, the vast majority, will be included only for medical record review.
Eligibility Criteria
Inclusion Criteria for clinics:
Clinic eligibility criteria include:
- More than one oncologist
- Serve a patient population that is at least 30% aged 65 or older
- Disease-based oncology clinic
Subject Eligibility: (for the in-person surveys):
- Any patient affiliated with one of the study clinics who speaks English and is aged 65 or older with advanced cancer is eligible for participation. Advanced cancer is defined as metastatic disease for solid tumors and recurrent or refractory disease for hematological malignancies. There are no exclusions based on gender, race, or ethnicity.
Exclusion Criteria
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Data sourced from ClinicalTrials.gov (NCT03609177). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.